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Circadian clocks are fundamental to the biology of most eukaryotes, 1	
coordinating behavior and physiology to resonate with the environmental cycle 2	
of day and night through complex networks of clock-controlled genes1-3. A 3	
fundamental knowledge gap exists however, between circadian gene expression 4	
cycles and the biochemical mechanisms that ultimately facilitate circadian 5	
regulation of cell biology4,5. Here we report circadian rhythms in the 6	
intracellular concentration of magnesium ions, [Mg2+]i, which act as a cell-7	
autonomous timekeeping component to determine key clock properties in both a 8	
human cell line and a unicellular alga that diverged from metazoans more than 1 9	
billion years ago6. Given the essential role of Mg2+ as a cofactor for ATP, a 10	
functional consequence of [Mg2+]i oscillations is dynamic regulation of cellular 11	
energy expenditure over the daily cycle. Mechanistically, we find that these 12	
rhythms provide bilateral feedback linking rhythmic metabolism to clock-13	
controlled gene expression. The global regulation of nucleotide triphosphate 14	
turnover by intracellular Mg2+ availability has potential to impact upon many of 15	
the cell’s >600 MgATP-dependent enzymes7 and every cellular system where 16	
MgNTP hydrolysis becomes rate limiting. Indeed, we find that circadian control 17	
of translation by mTOR8 is regulated through [Mg2+]i oscillations. It will now be 18	
important to identify which additional biological processes are subject to this 19	
form of regulation in tissues of multicellular organisms such as plants and 20	
humans, in the context of health and disease. 21	
 Circadian rhythms occur cell-autonomously and are not restricted to 22	
metazoans or multicellular organisms, being found throughout eukaryotes and some 23	
prokaryotes9. Although explicit clock gene identities share no similarity across 24	
phylogenetic kingdoms, in every case temporal orchestration of gene expression is 25	
driven by timekeeping mechanisms that result in rhythmic clock protein transcription 26	
factor activity. In human cells, for example, a heterodimeric complex of BMAL1 and 27	
CLOCK positively regulates the expression of genes (Period1/2, Cryptochrome1/2) 28	
that encode its own repressor complex9, whereas in the marine unicellular alga 29	
Ostreococcus tauri, a reduced version of the stereotypical plant-like circadian clock 30	
consists of a feedback loop between the morning-expressed MYB-like transcription 31	
factor CCA1 and the evening-expressed protein TOC110. Intriguingly, the role of 32	
enzymes such as casein kinase 1 and 2 in the post-translational regulation of clock 33	
protein activity/stability, and the speed at which biological clocks run, is functionally 34	
		 3	
conserved across eukaryotes11. Also, we recently reported a circadian rhythm in the 1	
redox state of peroxiredoxin proteins that is conserved across phylogenetic 2	
kingdoms4,12. Critically, this metabolic rhythm persists in the absence of nascent gene 3	
expression, both in human cells (anucleate erythrocytes)13 and in Ostreococcus, which 4	
ceases mRNA production upon prolonged photosynthetic inactivity under constant 5	
darkness14, indicating that circadian regulation of cellular metabolism is not strictly 6	
reliant upon rhythmic transcription. These and a number of other observations render 7	
it plausible that circadian rhythms observed in diverse eukaryotes incorporate features 8	
of a post-translational timing mechanism that was present in the last eukaryotic 9	
common ancestor, LECA15. 10	
A rich diversity of evolutionarily conserved membrane transporters and 11	
channels mediate uptake of ions and micronutrients essential for cellular 12	
biochemistry, with several studies having reported their circadian regulation in a 13	
variety of contexts (e.g.16), and with membrane models of the circadian clock actually 14	
predating the identification of any clock genes17,18. It is plausible that rhythmic 15	
regulation of ion transport may have conferred an adaptive advantage upon early 16	
eukaryotes, allowing the global regulation of biochemical equilibria and reaction rates 17	
to tune cellular metabolism with environmental cycles. We therefore asked whether 18	
circadian regulation of transmembrane ion transport might constitute a fundamental 19	
feature of circadian timekeeping in eukaryotic cells. To find evidence for such 20	
regulation in modern organisms, we compared two eukaryotic lineages separated by 21	
~1.5 billion years of evolution6: human U2OS cells and Ostreococcus tauri. 22	
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) was employed to 23	
generate an unbiased analysis of the total cellular elemental composition, including all 24	
organelles and cellular structures19,20, over circadian time series. In Ostreococcus, 25	
clear daily rhythms were detected under natural light/dark cycles for many different 26	
ions, including potassium and magnesium (Fig. 1a and Extended Data Fig. 1). 27	
Analyses of cells maintained under constant light revealed that, whilst rhythms of 28	
some metal ions ceased under these conditions, oscillations in potassium and 29	
magnesium persisted, indicating their regulation by cell-autonomous circadian clock 30	
mechanisms. Strikingly, circadian rhythms of magnesium and potassium were also 31	
observed in non-proliferating human U2OS cells maintained over three days under 32	
constant conditions (Fig. 1b and Extended Data Fig. 2). The oscillation in intracellular 33	
potassium is likely to be a consequence of rhythmic Na+-dependent pump activity, as 34	
		 4	
circadian regulation of sodium-dependent solute-transport and plasma membrane 1	
ATPases has been reported widely (e.g.2,16,21,22). Calcium is largely found in, and 2	
released from, intracellular stores and although calcium has a clearly established role 3	
in circadian rhythms11, we infer the absence of any obvious cell-autonomous Ca2+ 4	
oscillations to mean that its net cellular flux does not vary over the circadian cycle in 5	
these cells. We considered the oscillation in Mg2+ to be of particular interest, since 6	
Mg2+ is an essential cofactor for (deoxy-) nucleotide triphosphates. Cellular Mg2+ 7	
therefore has the potential to regulate many intracellular metabolic reactions, through 8	
its requirement for the activities of >600 enzymes7, including those involved in ATP 9	
production, as well as DNA, RNA and protein synthesis. Furthermore, free 10	
intracellular Mg2+ can act as a second messenger. For example, epidermal growth 11	
factor stimulation induces a rapid increase in [Mg2+]i, which acts via highly Mg-12	
sensitive mTOR to activate protein synthesis without any change in total ATP 13	
levels23. 14	
Firstly, we exploited the role of Mg2+ as an ATP cofactor, to measure freely 15	
available intracellular magnesium concentrations in cellular extracts using the 16	
MgATP-dependent enzyme firefly luciferase (Fig. 1c,d). Our initial ICP-MS 17	
observations were confirmed using this assay, and we observed clear rhythms of 18	
[Mg2+]i over two days under constant conditions in both cell types. Bioluminescent 19	
reporters for clock gene activity, recorded in parallel, confirmed the [Mg2+]i 20	
oscillation to occur roughly in antiphase with circadian markers normally expressed 21	
around (subjective) dawn (CCA1-LUC, Per2:luc, Fig. 1a,b). Conservation between 22	
human and algal cells indicates that rhythmic cation transport might constitute a 23	
general feature of cellular rhythmicity. We therefore investigated whether such 24	
oscillations were also present in the fungus Neurospora crassa, representing the third 25	
eukaryotic kingdom. Similar to our observations in algal and human cells, a circadian 26	
rhythm in cellular magnesium content was observed in antiphase with the abundance 27	
of the clock protein FRQ9 (Extended Data Fig. 3a-c). We also observed cellular 28	
magnesium rhythms in cultured mouse fibroblasts isolated from adult lung, indicating 29	
that magnesium rhythms are also present in non-transformed, terminally differentiated 30	
mammalian cells (Extended Data Fig. 3d). These rhythms were disrupted in 31	
fibroblasts isolated from Cryptochrome1-/-,Cryptochrome2-/- mice, suggesting their 32	
dependence upon clock gene activity. Incidentally, we note that approximately 24 h 33	
[Mg2+]i rhythms occur cell-autonomously, are temperature-compensated (Extended 34	
		 5	
Data Fig. 4) and entrain to relevant external cues and are therefore circadian by 1	
definition24. 2	
The rhythm in total cellular Mg2+ measured by ICP-MS must result from daily 3	
cycles between net cellular Mg2+ influx and efflux, through circadian regulation of 4	
plasma membrane Mg2+ channel and transporter activity7. All known magnesium 5	
transporting proteins in animals (channels TRPM7, MAGT1, MMGT1 and CNMM3, 6	
as well as Mg2+-transporter SLC41) exhibit circadian rhythms at the mRNA level in 7	
four or more tissues25 (Extended Data Fig. 5). Ostreococcus encodes homologs of 8	
TRPM7, CNMM3 and SLC41, which are also differentially expressed over the daily 9	
cycle (Extended Data Fig. 5). Moreover, siRNA-mediated knockdown of each Mg2+-10	
channel/transporter in U2OS cells results in lengthened circadian period26, suggesting 11	
that as well as being clock-regulated, [Mg2+]i might also feed back to regulate the 12	
cellular clock. 13	
To determine whether [Mg2+]i oscillations are relevant to timekeeping 14	
mechanism therefore, we next employed inhibitors of magnesium transport. 15	
Cobalt(III)hexammine (Co(NH3)62+, CHA) and cobalt(III)chloro-pentammine 16	
(Co(NH3)5Cl2+, CPA) closely resemble a single-solvation shell hydrated Mg2+ ion, 17	
and have been shown to block Mg2+ transport through at least two different 18	
transporters/channels27,28. We found both compounds to dose-dependently increase 19	
[Mg2+]i in both cell types (Fig. 2a,b and Extended Data Fig. 6), indicating that these 20	
compounds do act to block Mg2+ transport. Increased [Mg2+]i was associated with 21	
clear dose-dependent lengthening of circadian period (Fig. 2c-f). Importantly, the 22	
effects of CHA on circadian period were dependent on the concentration of 23	
extracellular magnesium (Extended Data Fig. 7a-d), indicating a specific role for 24	
magnesium in determining the speed at which both algal and human cellular clocks 25	
run. To further substantiate this observation, we used quinidine, an inhibitor that acts 26	
on several ion transport activities including the SLC41 Na+/Mg2+ antiporter29. 27	
Similarly to CHA and CPA, quinidine led to dose-dependent accumulation of 28	
intracellular Mg2+ and lengthening of circadian period in both cell types (Fig. 2). 29	
SLC41 constitutes the sole protein known to exhibit sodium-dependent Mg2+-30	
transport activity29 that is conserved between human and Ostreococcus cells and so, to 31	
test its specific cellular clock function, we performed siRNA-mediated SLC41 knock-32	
down: observing a clear Mg2+-dependent lengthening of circadian period (Extended 33	
Data Fig. 7e-g). 34	
		 6	
We also observed that depletion of magnesium from the growth medium led to 1	
reduced [Mg2+]i, and had dramatic effects on the amplitude and period of the circadian 2	
clock in Ostreococcus (Fig. 3a,b). Although prolonged growth in low Mg2+ media had 3	
adverse effects on cell viability of the U2OS line, cells that were simply transferred to 4	
Mg2+-free media showed reduced [Mg2+]i and exhibited circadian rhythms with 5	
increased period and decreased bioluminescence amplitude relative to normal media 6	
controls (Fig. 3c,d). In neither case was the effect of [Mg2+]i-depletion attributable to 7	
decreased ATP availability, since in both cases cellular ATP levels were significantly 8	
increased (Fig. 3b,d). 9	
Thus, as observed previously for cAMP signalling30, treatments which 10	
constitutively elevate or reduce [Mg2+]i both result in period lengthening of clock 11	
gene expression in these cell types, indicating that dynamic circadian regulation of 12	
[Mg2+]i might be a cellular clock component. On the other hand however, it remained 13	
possible that Mg2+ transport might not contribute to clock mechanism, but instead 14	
simply be permissive for cellular timekeeping, analogous to the function of 15	
‘housekeeping’ genes. To distinguish between these two possibilities, we determined 16	
whether an enforced transition in [Mg2+]i acts as a state variable for cellular circadian 17	
oscillations. Upon introduction of magnesium to Ostreococcus cells starved of 18	
magnesium, we observed strict resetting of the subsequent rhythm to subjective dawn, 19	
regardless of prior circadian phase, indicating that changes in [Mg2+]i can act as a 20	
strong zeitgeber (Extended Data Fig. 8). Therefore, our data indicate that not only 21	
does [Mg2+]i exhibit a bona fide circadian rhythm across diverse eukaryotic cells, but 22	
also that appropriate manipulation of [Mg2+]i is sufficient to determine the key 23	
properties of the oscillation (period, amplitude, and phase), making [Mg2+]i 24	
indistinguishable from a core clock component. 25	
We considered that the increased cellular ATP levels we observed during 26	
Mg2+ depletion might be attributable to differential sensitivity of MgATP-dependent 27	
cytosolic enzymes compared with the organellar ATP synthesis machinery. For 28	
example, ATP accumulation was accompanied by a marked reduction in extracellular 29	
lactate accumulation in U2OS cultures (Extended Data Fig. 9a), indicative of reduced 30	
glycolysis. We therefore considered whether rate-changes in gross cytosolic energy 31	
metabolism might be a functional consequence of cell-autonomous circadian [Mg2+]i 32	
oscillations. A clear prediction would be that global rates of translation should be 33	
		 7	
limited at circadian phases of low [Mg2+]i, since protein synthesis is one of the most 1	
energetically expensive processes that cells undertake. 2	
We assayed translation rate by puromycin incorporation8 in both cell types just 3	
before (anticipated) biological dusk and dawn; at the phase of lowest and highest 4	
[Mg2+]i, respectively. The Ostreococcus experiment was performed under its natural 5	
light/dark cycle so as to best model an organism in its natural environment, whereas 6	
the U2OS experiment was performed under constant conditions to model innate 7	
peripheral cellular clock function. We observed that both Ostreococcus and U2OS 8	
cells did exhibit significantly higher translation rates at the peak of [Mg2+]i, as 9	
predicted (Fig. 4c,d). In mammalian cells, the highly MgATP-sensitive mTOR 10	
pathway was recently shown to mediate circadian control of translation8. We 11	
hypothesised that [Mg2+]i oscillations might act via mTOR to effect circadian 12	
translational regulation, and tested this using two pharmacologically distinct mTOR 13	
inhibitors (torin1 and rapamycin). Both inhibitors lengthened period dose-14	
dependently, and abolished any additional period lengthening due to depletion of 15	
extracellular magnesium that was observed in controls. This clear ‘ceiling effect’ 16	
strongly suggests changes in [Mg2+]i act through mTOR activity to regulate cellular 17	
circadian period (Extended Data Fig. 9b-e). To test the extent to which marked 18	
differences in translation rates between dawn and dusk were attributable to cell-19	
autonomous [Mg2+]i oscillations, we incubated cells acutely with CHA to block 20	
magnesium transport before assaying overall translational rates. CHA significantly 21	
attenuated the difference in [Mg2+]i between dawn and dusk (Fig. 4a), and also phase-22	
dependently affected ATP levels (Fig. 4b). Crucially, differential translation rates 23	
were attenuated similarly by CHA treatment (Fig. 4c,d), indicating that in both cell 24	
types, circadian regulation of magnesium levels contributes to circadian rhythms in 25	
global translation rate. 26	
Our data support a model (Fig. 4e, Extended Data Fig. 10a) where the cellular 27	
clockwork regulates the expression of plasma membrane Mg2+ channels and 28	
transporters to generate rhythmic magnesium fluxes. These rhythms appear to 29	
facilitate the higher energetic demands and protein production of human cells during 30	
the (biological) day, as well as the global down-regulation of ATP turnover and 31	
translation in photosynthetic cells at night. Reciprocally, the [Mg2+]i rhythm feeds 32	
back to regulate the period, phase and amplitude of clock gene expression rhythms, 33	
acting as a “meta-regulator” to integrate metabolic rhythms with transcriptional 34	
		 8	
feedback models of cellular timekeeping. It is noteworthy however, that the 1	
magnesium rhythm observed in Ostreococcus persists under transcriptionally inactive 2	
conditions14 of constant darkness (Extended Data Fig. 10b,c), in the absence of 3	
transcriptional regulation of membrane transport. It is therefore likely that some 4	
aspects of circadian magnesium flux are regulated by, and may contribute to, the same 5	
uncharacterised non-transcriptional clock mechanism13,14 that also drive persistent 6	
peroxiredoxin overoxidation rhythms in transcriptionally inactive cells across taxa, 7	
and which we speculate was present in the LECA. 8	
Cell-autonomous rhythms in [Mg2+]i availability have the potential to impart 9	
circadian regulation to any cellular system where MgNTP hydrolysis becomes rate 10	
limiting. Although the clinical relevance of [Mg2+]i in various tissues is beginning to 11	
garner more attention, the interactions between magnesium transport and human 12	
health are poorly understood. Further investigation of the downstream consequences 13	
of circadian regulation of [Mg2+]i will therefore be important. 14	
  15	
		 9	
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Figure Legends 1	
Figure 1: Conserved cellular rhythms in intracellular magnesium 2	
concentrations. 3	
Time-series of lysates prepared from Ostreococcus (a, light/dark into constant light) 4	
or human U2OS cells (b, constant conditions) were subjected to Inductively Coupled 5	
Plasma Mass Spectrometry. Rhythms in magnesium concentration in cell lysates were 6	
confirmed with luciferase-based assays (c,d). Bioluminescence reporters for morning-7	
phased clock gene expression were analysed in parallel (CCA1-LUC and Per2:luc) 8	
during both assays. All plots show mean±SEM, with replicate numbers (n) indicated. 9	
P-values report significance by 2-way ANOVA for time vs. interaction for each 10	
element (a,b) or 1-way ANOVA (c,d). 11	
 12	
Figure 2: Chronic inhibition of magnesium transport leads to increased [Mg2+]i 13	
and long circadian period. 14	
Chronic inhibition of magnesium transport by CHA or quinidine increases [Mg2+]i 15	
(a,b) and increases circadian period (c-f), traces and period dose-response of the 16	
CCA1-LUC (Ostreococcus) or Per2:luc (U2OS cells) reporters are shown. All plots 17	
are mean±SEM, with replicate numbers (n) indicated, p-values report significance by 18	
1-way ANOVA and post-test for linear trend. 19	
 20	
Figure 3: Reduced [Mg2+]i affects properties of cellular timekeeping and leads to 21	
an increase in ATP. 22	
Bioluminescence traces showing reduced extracellular magnesium significantly 23	
affects amplitude and period length of circadian reporters in algal (a) and human cells 24	
(c). Low extracellular magnesium leads to decreased [Mg2+]i and increased [ATP]i in 25	
both cell types (b,d), measured after 4 days. All plots show mean±SEM, with 26	
replicate numbers (n) indicated, p-values (****p<0.0001, **p=0.01, *p=0.04) report 27	
significance by 1-way ANOVA (Ostreococcus) or t-test (U2OS). 28	
 29	
Figure 4: Magnesium transport phase-dependently affects cellular energy 30	
balance 31	
Cells were treated with CHA or vehicle during the second half of the day (black bars) 32	
or night (blue bars) to test acute effects on magnesium (a) and ATP (b) levels in both 33	
cell types. Incorporation of puromycin was analysed by western blot (c) then 34	
		 14	
quantified to give relative translation rates at the indicated times (d). Mean±SEM are 1	
shown, n=3, t-test significance reported (n.s., p>0.18). e, Simplified model for a 2	
feedback mechanism between circadian [Mg2+]i rhythms and the clockwork to 3	
temporally regulate global cellular metabolism; orange arrow represents extracellular 4	
stimuli. 5	6	
		 15	
Methods 1	
All materials were purchased from Sigma-Aldrich unless otherwise stated. ICP-MS 2	
data are reported as “parts per billion (µg/L)”, Mg2+ measured by luciferase assay are 3	
normalised to the highest value and reported as “% [Mg2+]i”. 4	
 5	
Ostreococcus tauri 6	
Wild-type cells or cells transgenically expressing a translational fusion of CCA1 to 7	
luciferase from the CCA1 promoter (CCA1-LUC) 10 were grown under 12h/12h 8	
light/dark cycles in artificial sea water (24 g/l NaCl, 4 g/l Na2SO4, 0.68 g/l KCl, 200 9	
mg/l NaHCO3, 100 mg/l KBr, 25 mg/l H3BO3, 3 mg/l NaF, plus hydrous salts: 50 mM 10	
MgCl2*6H2O, 10 mM CaCl2*2H2O, 0.1 µM SrCl*6H20), supplemented with 11	
Guillard's F/2 marine enrichment solution and 10 nM H2SeO3. Full medium was 12	
adjusted to a salinity of 30 ppt. 13	
Imaging and analysis of luminescent rhythms was performed as described31-33. For 14	
resetting experiments, magnesium-free media were removed with a multichannel 15	
pipette and replaced with magnesium-containing media. In all luminescent imaging 16	
experiments, 8 replicate wells constitute n=8, and presented experiments are 17	
representative of 3 or more replicate experiments. 18	
 For ICP-MS analyses, 30 ml culture was pelleted, washed three times in 1 M 19	
Sorbitol to remove sea water, and digested in 100 µl nitric acid (69%, ARISTAR 20	
grade, VWR International) spiked with 345 ppb indium (VWR International) at RT 21	
for ~3 hours. Samples were then diluted to a final concentration of 2% v/v nitric acid 22	
and 10 ppb Indium prior to analysis on an Agilent 7500ce with octopole reaction 23	
system.  Serial dilutions of ICP-Multi-element solution IV (Merck, Certipur) was used 24	
for calibration of all the metals analysed and to check for instrument drift. A standard 25	
reference material SRM1643e (NIST) was analysed to validate the calibration. Indium 26	
was used to correct for dilution errors introduced during handling. ICP-MS data 27	
reported is based on three replicate flasks, each sampled every timepoint (n=3). 28	
Results presented have been verified in a replicate experiment, and outliers were 29	
excluded if they were >2 S.D. from the mean. 30	
 Cell extracts for luminescent Mg2+ and ATP assays were made from 3 31	
replicates (n=3) of 5 ml cell culture, pelleted and washed with 1 M Sorbitol, and 32	
resuspended in 100 µl medium before adding 100 µl 2x extraction buffer (1% Triton 33	
X-100, 300 mM NaCl, 100 mM HEPES). 25 µl of extract was boiled and added to 75 34	
		 16	
µl of assay mix (40 mM HEPES, 1 mM luciferin, 0.05 mg/ml QuantiLum (Promega), 1	
and either 1 mM MgCl2 or 10 µM ATP). Luminescence was measured on a TopCount 2	
(Packard) plate reader against a standard curve. As Mg2+ ions that remain tightly 3	
bound to cellular macromolecules such as membrane components and DNA are not 4	
detected by this alternative assay, the relative amplitude of [Mg2+]i changes observed 5	
using this assay were substantially larger than measured by ICP-MS.  Quinidine, CHA 6	
and CPA were made up in medium and added 24 hours prior to cell lysis for chronic 7	
treatments. Results were verified in one or more replicate experiments. For puromycin 8	
experiments (Fig. 4), cobalt ammines or vehicle were added at ZT6 or ZT18, and 0.5 9	
mg/ml puromycin was added 20 minutes before harvesting cells at ZT11 and ZT23 10	
(required concentration and incubation time determined empirically to reduce 11	
expression from a constitutive promoter driving luciferase by ~half). Analysis of 12	
incorporation was performed as described for U2OS cells below. Loading control was 13	
RbcL (Coomassie). 14	
 To identify potential Ostreococcus transporter proteins, mammalian sequences 15	
for all classes of SLC and all known magnesium transporters were blasted onto the 16	
Ostreococcus proteome using DELTA-BLAST (NCBI), and gene models were then 17	
taken from the latest version of the Ostreococcus genome 34 using the Orcae service 35 18	
(Gent University). 19	
 20	
Neurospora crassa 21	
Plates with 25 ml of Vogel’s medium containing 2% glucose, 0.5% arginine, 22	
10 ng ml−1 biotin and 0.2% Tween 80 were inoculated with 106 conidia of wild-type 23	
ras-1bd strain and incubated under constant light for 48 h at 30 °C. Two 2-cm disks cut 24	
from the mycelial pad were placed in a series of 50 ml cultures (Vogel’s medium 25	
containing 0.03% glucose, 0.05% arginine and 10 ng ml−1 biotin). These cultures 26	
were incubated at 25 °C under constant light before staggered transfers at 4h intervals 27	
to constant darkness, shaking at 125 r.p.m. Mycelia were then washed 4 times in a 28	
falcon tube with 25ml of sterile water, dried on filtration paper and frozen in liquid 29	
N2, and stored at −80 °C. Samples were then lyophilised and ground to a powder. 30	
These samples were split into two: one for western blot analysis of FRQ oscillations 31	
(as described in 36) and one for ICP-MS analysis. ICP-MS was performed as described 32	
for Ostreococcus, except that the dissolved tissue was filtered through a 0.22 µM 33	
filter before application on ICP-MS. 34	
		 17	
 1	
Mammalian cells 2	
Human U2OS cells, purchased from ATCC, were stably transfected with Per2:luc and 3	
cultured between passage numbers 31-51 as described previously37, except that 10% 4	
FetalCloneTM II serum (HyCloneTM) was used in place of fetal bovine serum. Cells 5	
were mycoplasma-free (Mycoalert, Lonza) and authenticated by Multiplex PCR. Cells 6	
were seeded into 6, 24 or 96-well white plates at a density of 105 cells/ml, and 7	
incubated in a humidified incubator (37°C, 5% CO2) under 12 h:12 h 32:37°C 8	
temperature cycles until confluent for a minimum of 3 days. We confirmed previous 9	
reports that U2OS do not proliferate appreciably once confluent and that in the 10	
presence of B-27 supplement U2OS circadian period is not affected by the presence 11	
of additional serum during bioluminescence recordings (Extended Data Fig. 2b-d). 12	
We cannot formally exclude the rhythmic excretion of growth factors. Empirically we 13	
determined that upon transfer to constant 37°C Per2:luc bioluminescence peaks 14	
around the anticipated transition from 32°C to 37°C, and also 28 h after a 15	
media/serum change. To maximize intercellular synchrony therefore, for all U2OS 16	
experiments, media was changed at 4 h prior to the warm phase for HEPES-buffered 17	
“air medium”38 and then maintained at constant 37°C under a gas impermeable seal. 18	
Air medium stock was prepared as described previously38 and supplemented with 2% 19	
B-27 (Life Technologies, 50X), 300 µM luciferin (Biosynth AG), 1% glutamax (Life 20	
Technologies), 100 units/ml penicillin/100 µg/ml streptomycin, as well as 21	
FetalCloneTM II serum (HyCloneTM). Serum was present at 10% for every U2OS 22	
experiment except those performed with Mg-free air medium (and controls). Mg-free 23	
air medium was prepared from its individual components, replacing magnesium with 24	
sodium. The final osmolarity was adjusted to 350 mOsm with NaCl and sterile 25	
filtered. Bioluminescence recordings were performed in a lumicycle (Actimetrics), a 26	
LB962 plate reader (Berthold technologies) or an Alligator (Cairn Research). Primary 27	
fibroblasts were isolated from the lung tissue of adult Cryptochrome1-/-28	
,Cryptochrome2-/- male mice39 or wild type controls, and cultured as described 29	
previously38, then immortalized by serial passage40. All animal work was licensed 30	
under the UK Animals (Scientific Procedures) Act of 1986 with local ethical 31	
approval. For time courses, confluent cultures were instead synchronized by 2 h 32	
incubation with 100 nM dexamethasone, then changed to air medium supplemented as 33	
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described above, but containing 1% FetalCloneTM III (instead of II) serum 1	
(HyCloneTM). 2	
 For ICP-MS analyses cells were washed twice in a salt-free isosmotic buffer 3	
(300 mM sucrose, 10 mM Tris pH7.4, 350 mOsM) at room temperature to remove 4	
ions in the cell media. Cells were then digested in 65 % nitric acid supplemented with 5	
100 ppb cerium for 30 minutes at room temperature and flash frozen. Upon thaw, 6	
samples were heated at 90°C for 1 h then centrifuged at 18,000g for 20 minutes to 7	
remove any debris, then diluted 1:12 in HPLC-grade water to give a final matrix 8	
concentration of 5% HNO3. The ICP-MS time course data shown are representative of 9	
three separate time courses all with the indicated number of biological replicates per 10	
time point. ICP-MS was performed on a Perkin Elmer Elan DRC II. SPS-SW2 (LGC) 11	
was used as a routine standard but linear sensitivity was confirmed for each element 12	
(Extended data Fig. 2). Cerium in the HNO3 extraction reagent used to correct for 13	
dilution errors introduced during handling. Outliers were excluded if they were >2 14	
S.D. from the mean. 15	
 For intracellular ATP and Mg2+ assays, U2OS cells were washed twice with 16	
ice-cold PBS + 5 mM EDTA then lysed in buffer containing 30 mM HEPES pH 7.4, 17	
100 mM NaCl, 10% Glycerol, 1% Triton and 5 mM Na3VO4 then flash frozen. Mouse 18	
fibroblasts were instead lysed in 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% LDS, 19	
1% Triton, 0.5% NaDOC and protease inhibitors. Samples were thawed, and proteins 20	
denatured, by heating at 90°C for 10 minutes followed by centrifugation at 18,000 g 21	
at 4°C. Assays were performed by diluting samples 1:1 in 2X assay buffer giving final 22	
concentrations of 30 mM HEPES (pH 7.4), 1 mM luciferin, 50 nM QuantiLum 23	
(Promega) and either 15 mM MgSO4 or 100 µM ATP (dependent on whether ATP or 24	
Mg2+ was being assayed). For Mg2+ assays upon mouse fibroblast lysates, 5% bovine 25	
serum albumin was also included in the assay buffer to quench LDS. 26	
Bioluminescence was measured using a LB962 CentroPRO microplate reader 27	
(Berthold technologies) or Spark 10M microplate reader (Tecan). Lactate assay kits 28	
(MAK064-1KT) were used in accordance with manufacturer’s instructions and 29	
measured on a Spark 10M microplate reader (Tecan). SLC41A1 siRNA (Santa Cruz 30	
sc-88707) or control siRNA-A (Santa Cruz sc-37007) was used at 80 pM to 6 µl of 31	
transfection agent (Santa Cruz sc-29528) to transfect Per2:luc U2OS cells at 60% 32	
confluence in 35 mm2 dishes as per manufacturer’s instructions. Quinidine, 33	
rapamycin, torin1, CHA and CPA stock solutions were made up in serum and B-27-34	
		 19	
free air medium, with chronic treatments lasting for 24 h prior to enzymatic [Mg2+]i 1	
assay. For acute treatments, 2 mM CHA (final concentration) was added 3h prior to 2	
the peak or trough of Per2:luc bioluminescence and harvested 3h later. Puromycin 3	
labeling was performed for 10 minutes at 37°C with 10 µg/ml puromycin before cells 4	
were washed twice in ice-cold PBS + 5mM EDTA then lysed on ice for 20 minutes in 5	
buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% SDS, 1% Triton and 6	
0.5% sodium deoxycholate. Gel electrophoresis, transfer and blotting were performed 7	
as described previously4. SLC41A1 rabbit antibody (Abcam ab83701) was diluted by 8	
1:1000, and mouse monoclonal anti-puromycin ascites41 was diluted 1:100 in 9	
blocking buffer (w/v 0.25% BSA, 0.25 % dried skimmed milk in Tris-buffered 10	
saline/0.05% Tween-20) and incubated overnight with nitrocellulose membranes. 11	
Anti-β actin (sc-47778, Santa Cruz) was used as a loading control at 1:5000 dilution. 12	
U2OS impedence measurements were performed upon an xCELLigence RTPA DP 13	
under our standard bioluminescence recording conditions (air media with 14	
supplements, including 10% serum) according to the manufacturer’s instructions. 15	
 16	
Analysis 17	
Statistical tests were performed using Graphpad Prism, with all tests two-sided. No 18	
significant difference in variance was detected between groups under comparison, 19	
Brown-Forsythe’s test (p>0.2). Numbers of biological replicate numbers were chosen, 20	
based on preliminary experiments, so that an effect size of at least 10% could be 21	
detected between experimental groups for α=0.05 and β=0.9. For phase response 22	
curves the circular mean and standard deviation were calculated using the “circular” 23	
R package implementing the methods described previously42,43. A least squared fit of 24	
the phase response vs phase prior to addition to a linear model where the gradient was 25	
constrained to -1 was performed. The Y intercept where X=0 is indicative of the 26	
nascent phase relative to the prior phase in hours.  27	
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Extended Data Legends 1	
Extended Data Figure 1: Additional ICP-MS data and controls (Ostreococcus) 2	
Inductively Coupled Plasma Mass Spectrometry analyses of cell lysates from 12 h:12 3	
h light/dark cycles (a) or on the second day of constant light (b). P-values report 4	
significance by one-way ANOVA (mean±SEM, n=3). c, ICP-MS analyses on cell 5	
lysates compared with media control (no cells) and membrane fractions (lysed cells) 6	
(mean±SD plotted, n=2), indicating that magnesium signal in panel a and main Fig. 1 7	
comes predominantly from the intracellular space. Groups are significantly different 8	
by one-way ANOVA (p<0.0001) Tukey's multiple comparisons p-values are 9	
indicated. d. Fluctuations in measured concentrations are not related to fluctuations in 10	
cell size over time. No significance of time as source of variation in cell size was 11	
observed by FACS analyses (mean±SD plotted, one-way ANOVA p-value is 12	
indicated, n=5). 13	
 14	
Extended Data Figure 2: Additional ICP-MS data (U2OS cells) and controls 15	
a. Inductively Coupled Plasma Mass Spectrometry analyses of U2OS cell extracts for 16	
several stable isotopes of several biologically relevant ions (mean±SEM, grey/black, 17	
n≥4), with insets showing standards that indicate linearity over the observed 18	
concentration ranges (mean ± %CV). We compared how well a straight-line + 19	
damped sine wave model (adapted from44) fit to each time series compared with a 20	
straight-line only (null hypothesis, no rhythm). The null hypothesis was preferred in 21	
each case except for Mg and K (analysed by 24Mg and 39K), where the sinusoidal fit 22	
with a circadian period was preferred (blue line, R2 and fit period±SEM are reported). 23	
b. Bmal1:luc bioluminescence data showing no effect of serum concentration on 24	
circadian rhythms in U2OS cells in the presence of B-27 supplement. c. 25	
Quantification of period and amplitude for data shown in b, mean±SEM (n=3), one-26	
way ANOVA for period, p=0.79, one-way ANOVA for amplitude, p=0.01. d. 27	
Cellular impedance measurements indicate that U2OS cells do not proliferate upon 28	
reaching stationary phase under our assay conditions, reported doubling times (Td) 29	
were calculated from data collected between the dotted lines. 30	
 31	
Extended Data Figure 3: Circadian rhythms of [Mg2+]i in Neurospora crassa and 32	
mouse fibroblasts 33	
		 23	
a. Circadian regulation of [Mg2+]i detected by ICP-MS in the fungus Neurospora 1	
crassa under constant darkness (mean±SEM, n=3). b. Representative (out of 3) FRQ 2	
immunoblot sampled in parallel. c. Quantification of FRQ abundance (mean±SEM, 3	
n=3). d. Circadian regulation of [Mg2+]i measured by luciferase-based assay is 4	
dependent upon CRYPTOCHROME in immortalised adult mouse fibroblasts under 5	
constant conditions (mean±SEM, n=3). 6	
 7	
Extended Data Figure 4: Rhythms of [Mg2+]i entrain to relevant external cues 8	
and are temperature-compensated. 9	
a. Inversion of 12 h : 12 h light/dark entrainment cycles is sufficient to entrain the 10	
phase of [Mg2+]i in Ostreococcus cells, measured by luciferase assay under constant 11	
light (mean±SEM, n=3). b. From the start of the experiment (S), 3 days of 12 h : 12 h 12	
temperature cycles between 32 and 37 ºC, followed a change to air medium (M) is 13	
sufficient to entrain the phase of [Mg2+]i in U2OS cells measured by ICP-MS over 14	
two circadian cycles under constant conditions (mean±SEM, n=3). c. Ostreococcus 15	
bioluminescence recordings (CCA1-LUC) at the indicated temperatures (n=8). 16	
Vertical dotted lines indicate sampling window for Mg2+ assays reported in panel d: 17	
assays performed during the second cycle under constant conditions show that 18	
circadian [Mg2+]i rhythms are temperature compensated (n=4). Each data set was fit 19	
with a Lorentzian curve to estimate peak [Mg2+]i. e. No significant difference in 20	
temperature compensation (Q10) between CCA1-LUC rhythms and the timing of the 21	
second Mg2+i peak; unpaired t-test p-value is reported. 22	
 23	
Extended Data Figure 5: Human magnesium transporters and conservation in 24	
Ostreococcus tauri 25	
a. Ubiquitously expressed human proteins with a clearly defined Mg2+ transport 26	
activity7 are listed. Note that many additional putative Mg2+-transporters are 27	
annotated, with several of these also being circadian-regulated in multiple mouse 28	
tissues. b. Expression profiles of Ostreococcus homologs of mammalian Mg2+ 29	
channels & transporters listed in (a), mined from publically available microarray 30	
data45. 31	
a From BioGPS26,46 32	
b From CircaDB25 with JTK cycle p-value < 0.05. 33	
c From the Orcae service34,35 34	
		 24	
d % sequence identity/similarity with human protein sequence (E-value). DELTA-1	
BLAST47 performed using default settings. 2	
e From micro-array data45 shown in (b). 3	
 4	
Extended Data Figure 6: Chronic CPA treatment dose-dependently lengthens 5	
period 6	
Traces (a, b) of the CCA1-LUC (Ostreococcus) or per2:luc (U2OS cells) reporters, 7	
showing the effect of inhibition of magnesium transport by Co(NH3)5Cl2+ (CPA) upon 8	
period dose-response (c, d) and upon [Mg2+]i (e, f). All plots show mean±SEM, with 9	
replicate numbers (n) indicated, p-values report significance by 1-way ANOVA and 10	
post-test for linear trend. 11	
 12	
Extended Data Figure 7: Period lengthening by CHA and SLC41 knockdown is 13	
dependent upon extracellular magnesium. 14	
a. Extracellular magnesium-depletion and CHA act synergistically to lengthen 15	
circadian period in Ostreococcus cells (mean±SEM, n=4). b. Quantification of period 16	
lengthening by CHA at different concentrations of extracellular magnesium 17	
(mean±SEM, n=4), p-value for two-way ANOVA (interaction effect) is reported. c. 18	
Extracellular magnesium-depletion and CHA act synergistically to lengthen circadian 19	
period in human U2OS cells (mean±SEM, n=6). d. Quantification of period 20	
lengthening by CHA in Mg2+-depleted vs. normal media (mean±SEM, n=4), p-values 21	
for two-way ANOVA (interaction effect) and Fisher’s exact test are reported. e. 22	
Period lengthening due to knockdown of plasma membrane Mg2+/Na+ antiporter 23	
SLC41A1 is attenuated by depletion of extracellular magnesium (mean±SEM, n=8). f. 24	
Quantification of period lengthening due to knockdown of SLC41A1 in normal vs. 25	
Mg2+-depleted media (mean±SEM, n=8); two-way ANOVA interaction effect, 26	
p<0.0001, p-values for Sidak’s multiple comparisons test are also reported. g. 27	
Quantification of SLC41A1 knockdown efficacy, unpaired t-test p-values are 28	
reported, a representative immunoblot (of 3) is shown (mean±SEM, n=3). 29	
 30	
Extended Data Figure 8: Bioluminescence data of wedge experiment 31	
Peak expression phase of the clock protein CCA1 was analysed upon re-introduction 32	
of magnesium to cultures in low extracellular magnesium, to test whether the phase of 33	
cellular rhythms is dictated by the prior phase of entrainment or by this enforced 34	
		 25	
transition from low to high [Mg2+]i. a, Bioluminescence traces showing that circadian 1	
rhythms in Ostreococcus are reversibly attenuated by depletion of extracellular Mg2+, 2	
and restored by Mg2+ wash-in. b,e. Bioluminescence traces from cells in low 3	
extracellular magnesium (b; 5 µM, e; 20 µM) with rhythms rescued by release into 4	
media containing normal physiological concentrations of magnesium at the indicated 5	
times (vertical dotted lines) in constant light (LL), compared to their respective 6	
controls where no magnesium was added in (blue traces). Data from 7-8 replicate 7	
wells are shown in each panel. c,f. Summary graphs where results from b,e are plotted 8	
in circadian wedge graphs: peak phases of CCA1-LUC rhythms in untreated control 9	
cells (grey dots) are compared with peak phase of rhythms reinstated by introduction 10	
of physiological magnesium following depletion to 5 µM (c, red dots) or 20 µM (f, 11	
orange dots), revealing that the phase of resulting rhythms is dictated solely by the 12	
phase of magnesium reintroduction (blue line). d,g. radial plots of phase shift 13	
(mean±SD, circumferential axis) depicted in panels c and f, versus phase prior to 14	
addition of Mg2+ to normal levels (old phase, radial axis and colour). The expected 15	
phase responses for type 0 resetting (black dotted line) and no resetting (red dotted 16	
line) are indicated. The goodness of fit (r2) and Y intercept (Y0) to the type 0 model 17	
are shown. Dose-dependent effects of intracellular magnesium on a critical clock 18	
parameter are confirmed by the observation that resetting is less strong when 19	
magnesium was reintroduced to cells adapted to intermediate levels of extracellular 20	
magnesium (e-g) compared to lowest extracellular magnesium (b-d). 21	
 22	
Extended Data Figure 9: The effects of magnesium depletion and role of mTOR. 23	
a. Extracellular lactate was measured in U2OS cells after 24 hours in Mg2+-depleted 24	
compared with normal media. b,c. Combined action of extracellular magnesium 25	
depletion and mTOR inhibition using torin1 (b, n=3) or rapamycin (c, n=6) to 26	
lengthen circadian period in U2OS cells is less than additive (mean±SEM). d,e. 27	
Quantification of period lengthening due to torin1 (d, n=3) and rapamycin (e, n=6) in 28	
Mg2+-depleted compared with normal media (mean±SEM). Note the apparent ‘ceiling 29	
effect’ at high concentrations of both drugs, such that Mg2+-depletion elicits no 30	
additional lengthening of cellular circadian period. Two-way ANOVA interaction 31	
effect: p<0.0001 for both drugs vs. Mg2+, selected p-values for Sidak’s multiple 32	
comparisons test are also reported (n.s., p>0.33). 33	
 34	
		 26	
Extended Data Figure 10: Factors potentially contributing to maintenance of 1	
membrane electroneutrality in light of [Mg2+]i oscillations 2	
a. Model indicating potential ion fluxes that might explain how clock-regulated 3	
[Mg2+]i oscillations impact on global cellular metabolism whilst membrane 4	
electroneutrality is maintained, during the day versus the night. The observed phase 5	
dependency of acute CHA was different between Ostreococcus and U2OS cells (Fig. 6	
4a-c), and is consistent with the very different environmental niches inhabited by a 7	
marine alga compared with a peripheral human tissue. In Ostreococcus, CHA 8	
maintained  [Mg2+]i at daytime levels when added prior to the normal trough, resulting 9	
in increased nighttime translation and a concomitant reduction in relative ATP levels. 10	
This result suggests that Ostreococcus pumps magnesium out of the cell during the 11	
dark period, against a large electrochemical potential gradient (magnesium is the 12	
second most abundant cation in seawater, at 50 mM in this study) in order to globally 13	
down-tune ATP turnover. In U2OS cells, CHA treatment significantly reduced 14	
[Mg2+]i accumulation and translation rates as well as significantly increasing ATP 15	
levels when added prior to the [Mg2+]i peak. Human cells inhabit an environment 16	
where nutrient availability is homeostatically regulated (0.8 mM magnesium in cell 17	
culture medium). As such, circadian regulation of increased magnesium transport into 18	
the cell during the feeding, active phase of day serves to facilitate higher metabolic 19	
rate constants. Please note that light has no direct effect on the clock in human 20	
peripheral cells, instead being mediated by systemic cues. b-c. [Mg2+]i oscillations 21	
persist in transcriptionally inactive Ostreococcus cells kept in constant darkness, as 22	
analysed by both ICP-MS (b) and luciferase assay (c), indicating that circadian 23	
regulation of ion transport can occur post-translationally in addition to its 24	
transcriptional regulation (mean±SEM, n=3 for ICP-MS data and n=4 for luciferase 25	
assays). 26	 	27	
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